SCHEMBL26310031

SCHEMBL26310031

C=Cc1c(C=C)n(Cc2ccccc2)c2ccccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.58
P2RX4 Q99571 1/20 0.51
LMNA P02545 5/20 0.51
PSMD14 O00487 1/20 0.51
KDM4E B2RXH2 5/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
ALDH1A1 P00352 3/20 0.47
USP2 O75604 1/20 0.47
POLB P06746 1/20 0.47
SMN1; SMN2 Q16637 4/20 0.44
MAPK1 P28482 2/20 0.44
MAPT P10636 1/20 0.44
PGR P06401 1/20 0.43
FOLH1 Q04609 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.41
PKM P14618 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
NTRK1 P04629 1/20 0.40
CYP1A2 P05177 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21764050 0.87 CYP19A1 (0.50) CYP19A1P2RX4LMNAPSMD14KDM4E
SCHEMBL22368026 0.81 ALDH1A1 (0.50) LMNAKDM4EMEN1KMT2AALDH1A1
SCHEMBL28216521 0.77 CYP19A1 (0.58) CYP19A1P2RX4LMNAPSMD14KDM4E
SCHEMBL26309887 0.76 ALDH1A1 (0.38) LMNAPSMD14KDM4EMEN1KMT2A
SCHEMBL28026397 0.75 KDM4E (0.56) LMNAKDM4EALDH1A1POLBSMN1; SMN2
SCHEMBL30007452 0.74 CYP19A1 (1.00) CYP19A1P2RX4LMNAKDM4EMEN1
SCHEMBL151053 0.74 CYP19A1 (1.00) CYP19A1P2RX4LMNAKDM4EMEN1
Ammonia Solution, Strong SCHEMBL29210102 0.73 CYP19A1 (0.95) CYP19A1P2RX4LMNAKDM4EMEN1
SCHEMBL9398256 0.73 CYP19A1 (0.95) CYP19A1P2RX4LMNAKDM4EMEN1
Bromide SCHEMBL28888744 0.73 CYP19A1 (0.95) CYP19A1P2RX4LMNAKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230292591-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230292591-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES POF1B, FOSB, OSBP CYP19A1 1572/4885P2RX4 2745/4885LMNA 1446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.